Evy Lobbestael

2.6k total citations
33 papers, 1.7k citations indexed

About

Evy Lobbestael is a scholar working on Neurology, Molecular Biology and Cell Biology. According to data from OpenAlex, Evy Lobbestael has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 23 papers in Molecular Biology and 8 papers in Cell Biology. Recurrent topics in Evy Lobbestael's work include Parkinson's Disease Mechanisms and Treatments (28 papers), Fungal and yeast genetics research (9 papers) and Plant Gene Expression Analysis (7 papers). Evy Lobbestael is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (28 papers), Fungal and yeast genetics research (9 papers) and Plant Gene Expression Analysis (7 papers). Evy Lobbestael collaborates with scholars based in Belgium, United States and Italy. Evy Lobbestael's co-authors include Veerle Baekelandt, Jean‐Marc Taymans, Renée Vancraenenbroeck, Mark Cookson, Marc De Maeyer, Elisa Greggio, Loukia Parisiadou, Lixin Sun, Huaibin Cai and Chengsong Xie and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Gut.

In The Last Decade

Evy Lobbestael

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evy Lobbestael Belgium 22 1.1k 892 403 379 320 33 1.7k
Loukia Parisiadou United States 17 1.1k 1.0× 840 0.9× 542 1.3× 332 0.9× 649 2.0× 25 2.0k
Artem Bugayenko United States 7 793 0.7× 702 0.8× 331 0.8× 242 0.6× 320 1.0× 7 1.3k
Byoung Dae Lee South Korea 15 736 0.7× 879 1.0× 303 0.8× 217 0.6× 351 1.1× 19 1.6k
Haibing Jiang United States 15 1.3k 1.2× 1.1k 1.3× 437 1.1× 451 1.2× 810 2.5× 27 2.2k
Shinji Hadano Japan 24 792 0.7× 788 0.9× 168 0.4× 254 0.7× 260 0.8× 63 1.6k
Terina N. Martinez United States 15 1.2k 1.1× 748 0.8× 569 1.4× 496 1.3× 610 1.9× 18 2.1k
Nicoleta Moisoi United Kingdom 14 561 0.5× 973 1.1× 250 0.6× 222 0.6× 295 0.9× 29 1.6k
Adamantios Mamais United States 22 1.0k 1.0× 552 0.6× 610 1.5× 385 1.0× 300 0.9× 33 1.6k
Alice Kaganovich United States 21 1.7k 1.6× 907 1.0× 727 1.8× 434 1.1× 510 1.6× 26 2.2k
Ariadna Recasens Australia 13 1.0k 1.0× 647 0.7× 507 1.3× 238 0.6× 471 1.5× 17 1.9k

Countries citing papers authored by Evy Lobbestael

Since Specialization
Citations

This map shows the geographic impact of Evy Lobbestael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evy Lobbestael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evy Lobbestael more than expected).

Fields of papers citing papers by Evy Lobbestael

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evy Lobbestael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evy Lobbestael. The network helps show where Evy Lobbestael may publish in the future.

Co-authorship network of co-authors of Evy Lobbestael

This figure shows the co-authorship network connecting the top 25 collaborators of Evy Lobbestael. A scholar is included among the top collaborators of Evy Lobbestael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evy Lobbestael. Evy Lobbestael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leva, Francesca Di, Michele Filosi, Lisa J. Oyston, et al.. (2023). Increased Levels of the Parkinson’s Disease-Associated Gene ITPKB Correlate with Higher Expression Levels of α-Synuclein, Independent of Mutation Status. International Journal of Molecular Sciences. 24(3). 1984–1984. 3 indexed citations
2.
Kania, Elżbieta, Jaclyn S. Long, David G. McEwan, et al.. (2023). LRRK2 phosphorylation status and kinase activity regulate (macro)autophagy in a Rab8a/Rab10-dependent manner. Cell Death and Disease. 14(7). 436–436. 10 indexed citations
3.
Lobbestael, Evy, Veerle Baekelandt, Andrew A. Hicks, et al.. (2023). The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology. npj Parkinson s Disease. 9(1). 44–44. 11 indexed citations
4.
Perren, Anke Van der, Géraldine Gelders, Javier María Peralta Ramos, et al.. (2021). LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo. Neurotherapeutics. 18(2). 949–961. 12 indexed citations
5.
Baekelandt, Veerle, et al.. (2020). Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation. Frontiers in Neuroscience. 14. 376–376. 52 indexed citations
6.
Lee, Ho‐Su, Evy Lobbestael, Séverine Vermeire, João Sabino, & Isabelle Cleynen. (2020). Inflammatory bowel disease and Parkinson’s disease: common pathophysiological links. Gut. 70(2). 408–417. 114 indexed citations
7.
Iannotta, Lucia, Alice Biosa, Jillian H. Kluss, et al.. (2020). Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues. Cells. 9(11). 2344–2344. 38 indexed citations
8.
Waschbüsch, Dieter, Edith Ossendorf, Evy Lobbestael, et al.. (2019). Rab32 interacts with SNX6 and affects retromer-dependent Golgi trafficking. PLoS ONE. 14(1). e0208889–e0208889. 27 indexed citations
9.
Baekelandt, Veerle, et al.. (2018). LRRK2 Phosphorylation: Behind the Scenes. The Neuroscientist. 24(5). 486–500. 18 indexed citations
10.
Baekelandt, Veerle, et al.. (2018). Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization. Molecular Neurobiology. 56(8). 5273–5286. 16 indexed citations
11.
Lobbestael, Evy, et al.. (2016). Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation. Scientific Reports. 6(1). 33897–33897. 53 indexed citations
12.
Civiero, Laura, Maria Daniela Cirnaru, Alexandra Beilina, et al.. (2015). Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain. Journal of Neurochemistry. 135(6). 1242–1256. 52 indexed citations
13.
Rompuy, Anne‐Sophie Van, Evy Lobbestael, Anke Van der Perren, Chris Van den Haute, & Veerle Baekelandt. (2014). Long-Term Overexpression of Human Wild-Type and T240R Mutant Parkin in Rat Substantia Nigra Induces Progressive Dopaminergic Neurodegeneration. Journal of Neuropathology & Experimental Neurology. 73(2). 159–174. 25 indexed citations
14.
Vancraenenbroeck, Renée, Evy Lobbestael, Fangye Gao, et al.. (2014). In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2. Frontiers in Molecular Neuroscience. 7. 51–51. 42 indexed citations
15.
Lobbestael, Evy, Jing Zhao, Iakov N. Rudenko, et al.. (2013). Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle. Biochemical Journal. 456(1). 119–128. 79 indexed citations
16.
Vancraenenbroeck, Renée, Evy Lobbestael, S.D. Weeks, et al.. (2012). Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1824(3). 450–460. 20 indexed citations
17.
Taymans, Jean‐Marc, Renée Vancraenenbroeck, Alexandra Beilina, et al.. (2011). LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding. PLoS ONE. 6(8). e23207–e23207. 81 indexed citations
18.
Vancraenenbroeck, Renée, Evy Lobbestael, Marc De Maeyer, Veerle Baekelandt, & Jean‐Marc Taymans. (2011). Kinases as Targets for Parkinson's Disease: From Genetics to Therapy. CNS & Neurological Disorders - Drug Targets. 10(6). 724–740. 27 indexed citations
19.
Daniëls, Veronique, Renée Vancraenenbroeck, Bernard M. H. Law, et al.. (2010). Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. Journal of Neurochemistry. 116(2). 304–315. 107 indexed citations
20.
Parisiadou, Loukia, Chengsong Xie, Hyun Jin Cho, et al.. (2009). Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis. Journal of Neuroscience. 29(44). 13971–13980. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loukia Parisiadou Breakdown of academic impact, for papers by Artem Bugayenko Breakdown of academic impact, for papers by Byoung Dae Lee Breakdown of academic impact, for papers by Haibing Jiang Breakdown of academic impact, for papers by Shinji Hadano Breakdown of academic impact, for papers by Terina N. Martinez Breakdown of academic impact, for papers by Nicoleta Moisoi Breakdown of academic impact, for papers by Adamantios Mamais Breakdown of academic impact, for papers by Alice Kaganovich Breakdown of academic impact, for papers by Ariadna Recasens
Rankless by CCL
2026